1. Home
  2. XENE vs AGYS Comparison

XENE vs AGYS Comparison

Compare XENE & AGYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • AGYS
  • Stock Information
  • Founded
  • XENE 1996
  • AGYS 1963
  • Country
  • XENE Canada
  • AGYS United States
  • Employees
  • XENE N/A
  • AGYS N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • AGYS EDP Services
  • Sector
  • XENE Health Care
  • AGYS Technology
  • Exchange
  • XENE Nasdaq
  • AGYS Nasdaq
  • Market Cap
  • XENE 3.3B
  • AGYS 2.9B
  • IPO Year
  • XENE 2014
  • AGYS N/A
  • Fundamental
  • Price
  • XENE $40.68
  • AGYS $141.00
  • Analyst Decision
  • XENE Strong Buy
  • AGYS Strong Buy
  • Analyst Count
  • XENE 9
  • AGYS 5
  • Target Price
  • XENE $56.67
  • AGYS $137.80
  • AVG Volume (30 Days)
  • XENE 361.3K
  • AGYS 204.4K
  • Earning Date
  • XENE 11-12-2024
  • AGYS 01-21-2025
  • Dividend Yield
  • XENE N/A
  • AGYS N/A
  • EPS Growth
  • XENE N/A
  • AGYS 628.86
  • EPS
  • XENE N/A
  • AGYS 3.42
  • Revenue
  • XENE N/A
  • AGYS $254,579,000.00
  • Revenue This Year
  • XENE N/A
  • AGYS $20.67
  • Revenue Next Year
  • XENE $1,599.99
  • AGYS $21.77
  • P/E Ratio
  • XENE N/A
  • AGYS $40.68
  • Revenue Growth
  • XENE N/A
  • AGYS 17.05
  • 52 Week Low
  • XENE $35.53
  • AGYS $73.52
  • 52 Week High
  • XENE $50.99
  • AGYS $141.27
  • Technical
  • Relative Strength Index (RSI)
  • XENE 46.22
  • AGYS 66.10
  • Support Level
  • XENE $38.95
  • AGYS $130.83
  • Resistance Level
  • XENE $41.62
  • AGYS $142.64
  • Average True Range (ATR)
  • XENE 1.46
  • AGYS 4.41
  • MACD
  • XENE -0.13
  • AGYS 0.18
  • Stochastic Oscillator
  • XENE 38.06
  • AGYS 88.74

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.

About AGYS Agilysys Inc. (DE)

Agilysys Inc has been a leader in hospitality software, delivering innovative cloud-native SaaS and on-premise solutions for hotels, resorts and cruise lines, casinos, corporate food service management, restaurants, universities, stadiums, and healthcare. The Company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. Agilysys also is known for its world-class customer-centric service.

Share on Social Networks: